Investors

Shareholder information

Information for our shareholders, including significant shareholdings and advisors

Shareholder Information

Corporate Goverance

How we comply with the QCA code

Corporate Governance
Circles_e-therapeutics_AR18.png

Results, Reports and Presentations

View our latest releases

Latest reports
Circles_e-therapeutics_AR18.png

AIM Rule 26

Details required under Aim rule 26

AIM Rule 26

RNS alerts

02 Apr 2019 Director Shareholding
29 Mar 2019 Director Shareholding
20 Mar 2019 Add'l Price Monitoring Extn.

Email alerts

Partnering & Collaboration

Our NDD approach consistently generates potent and novel hits, assisting companies increase the productivity of their drug discovery.

Please get in touch at bd@etherapeutics.co.uk.